Babu et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005; 165: 447-452.
Wolk et al. Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108: 9-12.
Buchner et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007; 176(12): 1274-1280.
4: Marin JM, Carrizo SL, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005 Mar 19-25;365(9464°/1046-53.
5: Lianne M. Tomfohr, MS, Sonia Ancoli-Israel, PhD, Jose S. Loredo, MD, and Joel E. Dimsdale, MD. Effects of Continuous Positive Airway Pressure on Fatigue and Sleepiness in Patients with Obstructive SleepApnea: Data from a Randomized Controlled Trial. Sleep. 2011 January 1;Supported by grants HL44915 (JED), AG08415 (SAI),and RR 00827 (University of California San Diego General Clinical Research Center grant). 34(1): 121-126.
6: Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010 Mar; At the time of the writing of this manuscript, Dr Romero-Corral was supported by a Postdoctoral Fellowship from the American Heart Association. Dr Caples is supported by NIH grant HL99534. Dr Lopez-Jimenez is a recipient of a Clinical Scientist Development Award from the American Heart Association. Dr Somers is supported by NIH grants HL-65176, HL-73211, and 1UL1 RR024150, and by the Mayo Clinic College of Medicine. 137(3):711-9.
7: Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004 Jul; 59(7):618-22.